BLMN
Bloomin' Brands, Inc.
BLMN has the edge over NKE overall, supported by stronger modeled upside.
NKE
NIKE, Inc.
NKE has lower modeled downside risk, despite its lower overall score.
BLMN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
BLMN's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
BLMN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.3x | $10.12 | — |
| Cheap | 9.8x | $8.08 | -20% |
| Current | 12x | $10.12 | — |
| Fair | 22x | $18.19 | +80% |
| Expensive | 34x | $27.95 | +176% |
Historical ranges are pointers, not guarantees.
BLMN's PE is in its cheap range at 12x. If earnings grow as analysts expect, today's price would be 9.3x next year's earnings.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over BLMN in the historical PE scenario, which offers more potential upside but is not a forecast.
BLMN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect BLMN's earnings to grow, with its revenue and profitability holding steady. However, they disagree widely on these estimates.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
BLMN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.09 | +33% |
| Q3 2026 | $0.82 | +$1.49 |
| Q2 2026 | $0.31 | +$0.36 |
| Q1 2026 | $0.25 | +$0.28 |
| Q4 2025 | $0.10 | +$1.59 |
| Q3 2025 | -$0.67 | -$0.59 |
| Q2 2025 | -$0.05 | -117% |
| Q1 2025 | -$0.03 | -104% |
| Q4 2024 | -$1.49 | -158% |
BLMN has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
BLMN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $944.3M | +1.7% |
| Q2 2026 | $1B | +1.3% |
| Q1 2026 | $1.1B | +1% |
| Q4 2025 | $975.2M | +0.3% |
| Q3 2025 | $928.8M | -11% |
| Q2 2025 | $1B | -10% |
| Q1 2025 | $1B | -12% |
| Q4 2024 | $972M | -19% |
BLMN's revenue fell from its 2023 peak and has held roughly level since: $944M last quarter, up 1.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2% | +5.9 points |
| Q2 2026 | 3.8% | +0.8 points |
| Q1 2026 | 5.6% | +0.1 points |
| Q4 2025 | -1.4% | -3 points |
| Q3 2025 | -3.9% | -5.6 points |
| Q2 2025 | 3% | -1.2 points |
| Q1 2025 | 5.5% | -1 points |
| Q4 2024 | 1.7% | -3.1 points |
BLMN's operating margin was 2% last quarter, up 5.9 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over BLMN on profitability, with a higher operating margin.
BLMN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$39.2M | -$33.5M |
| Q2 2026 | $46.9M | +321% |
| Q1 2026 | $50.1M | +81% |
| Q4 2025 | $63.7M | -35% |
| Q3 2025 | -$5.7M | +$69.2M |
| Q2 2025 | $11.1M | +$35.4M |
| Q1 2025 | $27.7M | +211% |
| Q4 2024 | $97.7M | +58% |
BLMN has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
BLMN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -587K shares |
| 1 year | +0.6% | +543K shares |
| 3 years | -13% | -12.9M shares |
| 5 years | -21% | -22.1M shares |
| Available history | -4.6% | -4.1M shares |
BLMN has 86M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $18.2M |
| Q2 2024 | $14.6M |
| Q1 2024 | $232.9M |
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over BLMN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
BLMN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.4x | Moderate |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q2 2025 | 3.0x | Elevated |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 2.9x | Moderate |
BLMN's net debt is about 2.4 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over BLMN on leverage, with a lower net debt burden relative to earnings.
BLMN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.2 | Neutral |
| Stochastic | 53.6 | Neutral |
BLMN's weekly RSI is 56 (neutral) and its Stochastic is 54 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
BLMN PE vs Consumer Cyclical Sector
| Metric | BLMN | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 32% below |
| PE % | 31 | 47 | 16 pts below |
BLMN has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
BLMN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.32 | 8.6% above |
| 20 week MA | $9.35 | 8.2% above |
| 50 week MA | $7.86 | 29% above |
| 100 week MA | $8.25 | 23% above |
| 200 week MA | $15.7 | 36% below |
BLMN has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
BLMN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.7 | $19.0 | -13% |
| 2021 | $19.0 | $21.0 | +11% |
| 2022 | $21.0 | $21.0 | 0% |
| 2023 | $21.0 | $28.2 | +34% |
| 2024 | $28.2 | $12.3 | -56% |
| 2025 | $12.3 | $6.79 | -45% |
| 2026 YTD | $6.79 | $10.1 | +49% |
BLMN has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.